Concepedia

Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group

E.C. Faulkner, Lieven Annemans, L. Garrison, Mark Helfand, Anke‐Peggy Holtorf, John Hornberger, Dyfrig Hughes, Tracy Li, Daniel C. Malone, Katherine Payne,

Value in Health · 2012 · 159 citations · 34 references

DOIFull text

Open access

Concepts

References

34

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

Antonio C. Wolff, M. Elizabeth H. Hammond, Jared N. Schwartz et al. · Journal of Clinical Oncology · 2006 · 4.5K citations · Full text

, , +11

Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies

Milton C. Weinstein, John Hornberger, Magnus Johannesson et al. · Value in Health · 2003 · 1.2K citations · Full text

, , +9

Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers

Richard Simon, Seungmok Paik, Daniel F. Hayes · JNCI Journal of the National Cancer Institute · 2009 · 1K citations · Full text

, , +17

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

Andreas Hochhaus, S G O'Brien, François Guilhot et al. · Leukemia · 2009 · 845 citations

, , +5

Key principles for the improved conduct of health technology assessments for resource allocation decisions

Michael Drummond, J. Sanford Schwartz, Bengt Jönsson et al. · International Journal of Technology Assessment in Health Care · 2008 · 492 citations

, , +16